Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 79
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 66
Drug Discovery 43
Cardiovascular Drugs 42
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biopharmaceuticals 36
Biotechnology 33
Genomics 27
Clinical Trials 21
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Central Nervous System Drugs 18
Pharmaceuticals 18
Allergy and Immunology 17
Infectious Diseases Drugs 16
Respiratory Drugs 15
Drugs by Therapeutic Area 14
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Drug Delivery 5
Gastroenterology 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Anti-Obesity Drugs 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

662 Results (Page 13 of 34)
- Relevance
  Sort by

Inhalable Drugs - Global Strategic Business Report

 Report
December 2025
270 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
48 Pages
Global

From

€1763EUR$2,000USD£1,538GBP

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

 Report
December 2023
134 Pages
Global

From

€2182EUR$2,475USD£1,903GBP

€4364EUR$4,950USD£3,806GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
December 2025
193 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Aflibercept Market - Global Forecast 2025-2032

 Report
November 2025
181 Pages
Global

From

€3126EUR$3,545USD£2,726GBP

€3473EUR$3,939USD£3,029GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

 Report
November 2022
175 Pages
Global

From

€3174EUR$3,600USD£2,768GBP

Cervical Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1763EUR$2,000USD£1,538GBP

€2204EUR$2,500USD£1,922GBP

Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035

 Report
December 2025
120 Pages
Global

From

€4231EUR$4,799USD£3,690GBP

Dermatological Drugs Market Report 2024-2034

 Report
February 2024
280 Pages
Global

From

€5163EUR$6,061USD£4,350GBP

Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions

 Report
March 2025
309 Pages
Global

From

€3967EUR$4,499USD£3,459GBP

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

 Report
December 2025
272 Pages
Global

From

€5158EUR$5,850USD£4,498GBP

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
99 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
289 Pages
Global

From

€2204EUR$2,500USD£1,922GBP

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
67 Pages
Global

From

€1763EUR$2,000USD£1,538GBP

Melanoma Therapeutics: Global Markets

 Report
November 2023
131 Pages
Global

From

€4100EUR$4,650USD£3,575GBP

Cardiovascular Collaboration and Licensing Deals 2016-2025

 Report
October 2025
300 Pages
Global

From

€3522EUR$3,995USD£3,072GBP

Colorectal Cancer Drugs Market - Global Forecast 2025-2032

 Report
November 2025
185 Pages
Global

From

€3126EUR$3,545USD£2,726GBP

€3473EUR$3,939USD£3,029GBP

Fallopian Tube Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1763EUR$2,000USD£1,538GBP

€2204EUR$2,500USD£1,922GBP

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
121 Pages
Middle East

From

€1763EUR$2,000USD£1,538GBP

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

 Report
January 2023
90 Pages
Global

From

€3081EUR$3,495USD£2,687GBP

662 Results (Page 13 of 34)
- 1
- 11
- 12
- 13
- 14
- 15

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.